Shareholders in Recursion Pharmaceuticals (NASDAQ:RXRX) have lost 46%, as stock drops 7.9% this past week
yahoo.com
news
2022-10-20 19:17:33

While not a mind-blowing move, it is good to see that the Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) share price has gained 18% in the last three months. But that doesn't change the reality of under-performance over the last twelve months. The cold reality is that the stock has dropped 46% in one year, under-performing the market.

Given the past week has been tough on shareholders, let's investigate the fundamentals and see what we can learn.

See our latest analysis for Recursion Pharmaceuticals

Given that Recursion Pharmaceuticals didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development.
